Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites
暂无分享,去创建一个
J. Palacios | D. Hoyer | Á. Pazos | A. Probst | A. Probst | J. M. Palacios | A. Pazos | D. Hoyer
[1] J. Palacios,et al. The distribution of serotonin receptors in the human brain: high density of [3H]LSD binding sites in the raphe nuclei of the brainstem , 1983, Brain Research.
[2] I. Lucki,et al. Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat. , 1984, The Journal of pharmacology and experimental therapeutics.
[3] R. Guggenheim,et al. Supraependymal nerve fibres in human brain: Correlative transmission and scanning electron microscopical and fluorescence histochemical studies , 1980, Neuroscience.
[4] J. Palacios,et al. The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site. , 1984, European journal of pharmacology.
[5] Michael J. Kuhar,et al. Quantitative receptor autoradiography using [3H]Ultrofilm: application to multiple benzodiazepine receptors , 1982, Journal of Neuroscience Methods.
[6] J. Leysen,et al. [3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role. , 1982, Molecular pharmacology.
[7] J. Palacios,et al. [3H]Spiperone binding sites in brain: autoradiographic localization of multiple receptors , 1981, Brain Research.
[8] S H Snyder,et al. Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol. , 1979, Molecular pharmacology.
[9] D. Hoyer,et al. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin. , 1985, European journal of pharmacology.
[10] H. Steinbusch,et al. Distribution of serotonin-immunoreactivity in the central nervous system of the rat—Cell bodies and terminals , 1981, Neuroscience.
[11] F. Artaud,et al. Biochemical evidence for the 5-HT agonist properties of PAT (8-hydroxy-2-(di-n-propylamino)tetralin) in the rat brain. , 1984, European journal of pharmacology.
[12] D. Taylor,et al. Involvement of 5-HT2 receptors in the wet-dog shake behaviour induced by 5-hydroxytryptophan in the rat , 1983, Neuropharmacology.
[13] R. Schnellmann,et al. 3H-serotonin binding sites: pharmacological and species differences. , 1983, Advances in biochemical psychopharmacology.
[14] J. Palacios,et al. Multiple opiate receptor in human brain: an autoradiographic investigation. , 1983, Life sciences.
[15] J. Palacios,et al. Serotonin receptors in the human brain. I. Characterization and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites , 1986, Brain Research.
[16] A. Closse. [3H]Mesulergine, a selective ligand for serotonin-2 receptors. , 1983, Life sciences.
[17] L. Iversen,et al. Reduced binding of [3H]ketanserin to cortical 5-HT2 receptors in senile dementia of the Alzheimer type , 1984, Neuroscience Letters.
[18] T. Crow,et al. Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides , 1984, Neuropharmacology.
[19] J. Palacios,et al. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors , 1985, Brain Research.
[20] J. Glowinski,et al. Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT , 1983, Nature.
[21] D. Neary,et al. Biochemical Assessment of Serotonergic and Cholinergic Dysfunction and Cerebral Atrophy in Alzheimer's Disease , 1983, Journal of neurochemistry.
[22] R. Lefkowitz,et al. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. , 1980, The Journal of biological chemistry.
[23] H. Davson. Physiology of the Cerebrospinal Fluid , 1967 .
[24] J. Boissier,et al. Biochemical assessment of the central 5-HT agonist activity of RU 24969 (a piperidinyl indole). , 1980, European journal of pharmacology.
[25] P. Janssen,et al. The head-twitch response to intraperitoneal injection of 5-hydroxytryptophan in the rat: Antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, an LSD antagonist , 1983, Neuropharmacology.
[26] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[27] P. Hartig,et al. 125I-lysergic acid diethylamide binds to a novel serotonergic site on rat choroid plexus epithelial cells , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[28] J. Palacios,et al. Distribution of α2-adrenergic receptors in the human brainstem: An autoradiographic study using [3H]p-aminoclonidine , 1984 .
[29] J. Leysen,et al. Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors. , 1981, Life sciences.
[30] J. Palacios,et al. Mesulergine, a selective serotonin-2 ligand in the rat cortex, does not label these receptors in porcine and human cortex: evidence for species differences in brain serotonin-2 receptors. , 1984, European journal of pharmacology.
[31] K. O'Shaughnessy,et al. Inhibition of 5-hydroxytryptamine-mediated behaviour by the putative 5-HT2 antagonist pirenperone , 1983, Neuropharmacology.
[32] J. Palacios,et al. Quantitative light microscopic autoradiographic localization of cholinergic muscarinic receptors in the human brain: Brainstem , 1984, Neuroscience.
[33] J. Green,et al. Characterization and radioautography of [3H]LSD binding by rat brain slices in vitro: the effect of 5-hydroxytryptamine. , 1980, European journal of pharmacology.
[34] J. Maloteaux,et al. Characterization and regional distribution of serotonin S2-receptors in human brain , 1983, Brain Research.
[35] C. Oberlander,et al. The interaction of indole derivatives with the serotonin receptor and non-dopaminergic circling behaviour. , 1981, Advances in experimental medicine and biology.
[36] A. Cross,et al. Serotonin Receptor Changes in Dementia of the Alzheimer Type , 1984, Journal of neurochemistry.